MedTrace Logo

Safety, Radiological and Patient Reported Outcomes of i-FACTOR+ Matrix Bone Graft Device - A Canadian, Multicenter, Post-Market Clinical Investigation

NCT05144126 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2021-12-03

No results posted yet for this study

Summary

The study intends tracking the usage patterns of a Bonegraft device within spine surgery in a multicenter setting in Canada.

Conditions

  • Degenerative Disc Disease

Interventions

OTHER

CT radioraphic assessment

CT radioraphic assessment

Sponsors & Collaborators

  • Talosix

    collaborator UNKNOWN

  • Medical Metrics Diagnostics, Inc

    collaborator INDUSTRY

  • CeraPedics, Inc

    lead INDUSTRY

Principal Investigators

  • Christopher Witiw, MD · St Michael's Hosptal Toronto

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-31
Primary Completion
2024-05-31
Completion
2025-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05144126 on ClinicalTrials.gov